- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 14 Feb 2024
- latest of these filings; the earliest 14 Feb 2024
- Managers listing it
- 2
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 1 listed it in both
- Shares listed
- 289,295
- combined, among listed positions
- Reported value
- $1.1m
- combined, at the quarter end
Among the 93 comparable managers: 2 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing CLNE in Q4 2023
2 of 2 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| PDT Partners LLC | 195,128 | $747k | 0.08% | Added | +19,900 | 14 Feb 2024 (the filing on sec.gov) |
| Caxton Associates LLP | 94,167 | $361k | under 0.1% | New | new | 14 Feb 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Caxton Associates LLPnew position · 94,167 shares now+94,167
- PDT Partners LLCexisting position · 195,128 shares now+19,900
Reductions
No reduction among listed positions.
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 1 | $29k | n.a. | n.a. |
| Q3 2013 | 1 | $1.9m | n.a. | n.a. |
| Q4 2013 | 1 | $1.9m | n.a. | n.a. |
| Q1 2014 | 1 | $1.3m | n.a. | n.a. |
| Q2 2014 | 1 | $9.4m | n.a. | n.a. |
| Q3 2014 | 1 | $6.2m | n.a. | n.a. |
| Q4 2014 | 1 | $199k | n.a. | n.a. |
| Q1 2015 | 1 | $174k | n.a. | n.a. |
| Q2 2015 | 1 | $147k | n.a. | n.a. |
| Q3 2015 | 1 | $212k | n.a. | n.a. |
| Q4 2015 | 1 | $169k | n.a. | n.a. |
| Q3 2016 | 1 | $1.9m | n.a. | n.a. |
| Q4 2016 | 2 | $1.3m | n.a. | n.a. |
| Q1 2017 | 1 | $719k | n.a. | n.a. |
| Q2 2017 | 1 | $536k | n.a. | n.a. |
| Q1 2021 | 1 | $9.0m | n.a. | n.a. |
| Q2 2021 | 1 | $406k | n.a. | n.a. |
| Q3 2021 | 1 | $6.6m | n.a. | n.a. |
| Q4 2021 | 1 | $425k | n.a. | n.a. |
| Q1 2022 | 1 | $1.2m | n.a. | n.a. |
| Q2 2022 | 1 | $707k | n.a. | n.a. |
| Q3 2022 | 2 | $22m | n.a. | n.a. |
| Q4 2022 | 1 | $5.7m | n.a. | n.a. |
| Q3 2023 | 2 | $7.7m | n.a. | n.a. |
| Q4 2023 | 2 | $1.1m | 2 | 0 |
| Q1 2024 | 2 | $984k | 1 | 0 |
| Q4 2024 | 1 | $87k | 1 | 0 |
| Q3 2025 | 1 | $821k | 1 | 0 |
| Q4 2025 | 1 | $721k | 18 | 6 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
CLNE and GEV →CLNE and XOM →CLNE and CVX →Choose a stock to compare with CLNE →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own CLNE, latest filings →Back to the 13F Explorer →